www.reviewofoptometry.com
Open in
urlscan Pro
188.114.96.3
Public Scan
URL:
https://www.reviewofoptometry.com/
Submission: On November 25 via api from CA — Scanned from NL
Submission: On November 25 via api from CA — Scanned from NL
Form analysis 1 forms found in the DOM
<form class="gsc-search-box gsc-search-box-tools" accept-charset="utf-8">
<table cellspacing="0" cellpadding="0" role="presentation" class="gsc-search-box">
<tbody>
<tr>
<td class="gsc-input">
<div class="gsc-input-box" id="gsc-iw-id1">
<table cellspacing="0" cellpadding="0" role="presentation" id="gs_id50" class="gstl_50 gsc-input" style="width: 100%; padding: 0px;">
<tbody>
<tr>
<td id="gs_tti50" class="gsib_a"><input autocomplete="off" type="text" size="10" class="gsc-input" name="search" title="search" aria-label="search" id="gsc-i-id1" dir="ltr" spellcheck="false"
style="width: 100%; padding: 0px; border: none; margin: 0px; height: auto; outline: none;"></td>
<td class="gsib_b">
<div class="gsst_b" id="gs_st50" dir="ltr"><a class="gsst_a" href="javascript:void(0)" title="Clear search box" role="button" style="display: none;"><span class="gscb_a" id="gs_cb50" aria-hidden="true">×</span></a></div>
</td>
</tr>
</tbody>
</table>
</div>
</td>
<td class="gsc-search-button"><button class="gsc-search-button gsc-search-button-v2"><svg width="13" height="13" viewBox="0 0 13 13">
<title>search</title>
<path
d="m4.8495 7.8226c0.82666 0 1.5262-0.29146 2.0985-0.87438 0.57232-0.58292 0.86378-1.2877 0.87438-2.1144 0.010599-0.82666-0.28086-1.5262-0.87438-2.0985-0.59352-0.57232-1.293-0.86378-2.0985-0.87438-0.8055-0.010599-1.5103 0.28086-2.1144 0.87438-0.60414 0.59352-0.8956 1.293-0.87438 2.0985 0.021197 0.8055 0.31266 1.5103 0.87438 2.1144 0.56172 0.60414 1.2665 0.8956 2.1144 0.87438zm4.4695 0.2115 3.681 3.6819-1.259 1.284-3.6817-3.7 0.0019784-0.69479-0.090043-0.098846c-0.87973 0.76087-1.92 1.1413-3.1207 1.1413-1.3553 0-2.5025-0.46363-3.4417-1.3909s-1.4088-2.0686-1.4088-3.4239c0-1.3553 0.4696-2.4966 1.4088-3.4239 0.9392-0.92727 2.0864-1.3969 3.4417-1.4088 1.3553-0.011889 2.4906 0.45771 3.406 1.4088 0.9154 0.95107 1.379 2.0924 1.3909 3.4239 0 1.2126-0.38043 2.2588-1.1413 3.1385l0.098834 0.090049z">
</path>
</svg></button></td>
<td class="gsc-clear-button">
<div class="gsc-clear-button" title="clear results"> </div>
</td>
</tr>
</tbody>
</table>
</form>Text Content
Toggle navigation
Leadership in clinical care
×
search
* HOME
* CE
* TOPICS
* * Case Reports
* Coding
* Contact Lenses & Solutions
* Cornea
* Diagnostics
* Dry Eye
* Eyelids
* Glaucoma
* Low Vision
* Neuro-ophthalmic Disorders
* News
* Ophthalmic Lenses & Dispensary
* Optometric Study Center
* Pharmaceuticals
* Practice Management
* Products
* Retina
* Surgery
* Systemic Disease
* Technology
* Multimedia
* Web Exclusives
* EVENTS
* * CE Programs
* Educational Programs (Non-CE)
* JOBS
Today's Spotlight
COMANAGE WITH CAUTION
With refractive surgery complications, which doctor is culpable?
Read More
Today's Spotlight
UNDERSTANDING THE OCULAR MANIFESTATIONS OF HSV
Herpes simplex virus (HSV) is an enveloped, linear, double-stranded DNA virus
belonging to the Alphaherpesvirinae family, made up of HSV type 1 (HSV-1), HSV
type 2 (HSV-2) and varicella zoster virus (VZV); in this article, we will focus
on the first two. HSV keratitis is thought to be a leading cause of blindness in
developed nations. Diagnosis can be challenging, as the virus can present with a
wide range of signs and symptoms. Here, we aim to educate clinicians on the
varying clinical presentations and available treatment options to help our
patients achieve ideal outcomes.
Read More
Today's Spotlight
BETWEEN THE SEPTAL DIVIDE: MANAGING PRESEPTAL AND ORBITAL CELLULITIS
Learn how to differentiate and handle these conditions.
Read More
Today's Spotlight
DISTINGUISHING EPISCLERITIS FROM SCLERITIS IN OPTOMETRIC PRACTICE
Timely and accurate differentiation between these two is essential for proper
management and to prevent severe ocular and systemic complications.
Read More
Today's Spotlight
THE CLINICAL TRIALS THAT CHANGED EYE CARE
Here’s your guide to over 60 landmark studies that established the protocols of
optometry as it’s practiced today.
Read More
Nov 24
Nov 23
Nov 22
Nov 21
Nov 20
THE NEWS FEED
PATTERNS OF NERVE FIBER LAYER DEFECTS HELP DISTINGUISH GLAUCOMA FROM MS
November 22, 2024
META-ANALYSIS FAVORS ORAL AZITHROMYCIN OVER DOXY FOR MGD
November 22, 2024
CHOROIDAL CHANGES LINKED TO HOAS IN MYOPIA
November 22, 2024
LIVING IN THE SOUTHERN US, POORER HEALTH STATUS LINKED TO LIKELIHOOD OF DIABETIC
RETINOPATHY
November 21, 2024
ANTICOAGULATION MANAGEMENT FOR MIGS STILL VARIED AMONG SUBSPECIALISTS
November 21, 2024
SEVERE DED PATIENTS HAVE THICKER CORNEAL EPITHELIUM, THINNER STROMA
November 21, 2024
AUTOMATED PUPILLOMETRY USEFUL TOOL FOR EVALUATING ANISOCORIA
November 20, 2024
STUDY SAYS ENVIRONMENTAL INFLUENCES ON MYOPIA DEVELOPMENT UNDERESTIMATED
November 20, 2024
CHOROIDAL CHANGES IN DEEP DIVERS RESEMBLES PACHYROID PIGMENT EPITHELIOPATHY
November 20, 2024
LOW-INCOME COUNTRIES HAVE HIGHER PREVALENCE AND MORTALITY RATES OF
RETINOBLASTOMA
November 19, 2024
STUDY OBSERVES PERIPHERAL DRUSEN-LIKE DEPOSITS IN 4.9% OF HIGHLY MYOPIC EYES
November 19, 2024
SS-OCT EFFECTIVELY DISTINGUISHES KERATOCONUS, PELLUCID MARGINAL DEGENERATION
November 19, 2024
SCHOOL-BASED VISION PROGRAMS “BRIDGE THE GAP” TO EYE CARE, BUT FALL SHORT
November 18, 2024
ADULTS WITH VISION DIFFICULTIES FACE GREATER DISPARITIES IN HEALTHCARE ACCESS
November 18, 2024
LONG-TERM NITROGEN DIOXIDE EXPOSURE LEADS TO NEARLY 50% INCREASED RISK OF
CATARACT
November 15, 2024
NINE IN 10 STUDENTS WHO FAILED SCHOOL VISION SCREENING HAD REFRACTIVE ERROR
November 15, 2024
DOPAMINE PRECURSOR LINKED TO 32% RISK REDUCTION IN NEW-ONSET GA DETECTION
November 15, 2024
IN US, ENUCLEATION FROM RETINOBLASTOMA STILL PREVALENT AMONG HISPANICS AND RURAL
POPULATIONS
November 14, 2024
FOUR TO EIGHT HOURS POST-CATARACT SURGERY IS OPTIMAL TIME TO MEASURE IOP
November 14, 2024
UVEITIS AFFECTS PHYSICAL AND MENTAL HEALTH, DAILY FUNCTIONING
November 14, 2024
E-CIGARETTE USE INCREASES UVEITIS RISK, STUDY FINDS
November 13, 2024
VA MIGHT NOT BE BEST MEASURE FOR IRD PROGRESSION
November 13, 2024
CLINICIANS ADVISED TO MONITOR ORTHO-K PATIENTS BEFORE REFRACTIVE SURGERY
November 13, 2024
SEVERE DRY EYE RAISES RISK OF CORNEAL ULCER FIVEFOLD, STUDY FINDS
November 12, 2024
SGLT2 INHIBITORS LINKED TO REDUCED GLAUCOMA RISK IN PATIENTS WITH TYPE 2
DIABETES
November 12, 2024
NERVE GROWTH FACTOR THERAPY IMPROVES VA IN NK PATIENTS
November 12, 2024
GLAUCOMA PRS THRESHOLD IDENTIFIES PATIENTS AT LOW RISK OF PROGRESSION
November 11, 2024
ACADEMY OF OPHTHALMOLOGY REPORT VALIDATES MULTIFOCAL CL USE FOR MYOPIA
November 11, 2024
LIKELIHOOD OF RRD ABOUT THREEFOLD GREATER WITH TOPICAL PILOCARPINE USE
November 08, 2024
CHOROIDAL THICKNESS, VASCULARITY INDEX HELP STRATIFY AMD PROGRESSION RISK
November 08, 2024
IIH TIED TO OBESITY MAY BE UNDERDIAGNOSED IN WOMEN
November 08, 2024
NEW WEEKLY CONTACT LENS PROMISES CONTINUOUS COMFORT
November 07, 2024
GEOGRAPHIC ATROPHY APPEARS LARGER ON STANDARD FIELD THAN UWF FAF
November 07, 2024
BACTERIA COMMON BUT BENIGN PRESENCE ON PUNCTAL AND CANALICULAR INSERTS
November 07, 2024
OHT-TO-GLAUCOMA CONVERSION RATE 17%, LARGE STUDY FINDS
November 07, 2024
SEMAGLUTIDE DOESN’T INCREASE NAION RISK IN GENERAL POPULATION, STUDY SHOWS
November 06, 2024
EPIGENETIC AGE ACCELERATION LINKED TO FASTER GLAUCOMA PROGRESSION
November 06, 2024
SEMAGLUTIDE DOESN’T INCREASE NAION RISK IN GENERAL POPULATION, STUDY SHOWS
November 06, 2024
REPEATED LOW-LEVEL RED LIGHT THERAPY EFFECTIVE AGAINST MYOPIA OVER TWO YEARS
November 06, 2024
STUDY IDENTIFIES NOVEL SUSCEPTIBILITY LOCUS FOR MYOPIC MNV
November 05, 2024
SMALL ADDITIONAL POAG RISK ASSOCIATED WITH AMLODIPINE USE, LARGE STUDY SHOWS
November 05, 2024
SLEEP APNEA POSES INCREASED RISK OF HIGH IOP
November 05, 2024
DR SEVERITY ASSOCIATED WITH NUMBER OF INTRARETINAL MICROVASCULAR ABNORMALITIES
November 04, 2024
STUDY: DMEK PATIENTS MAINTAIN GOOD ACUITY TEN YEARS POST-OP
November 04, 2024
LATE-STAGE AMD INCURS HIGH ECONOMIC BURDENS
November 04, 2024
NEW EJOURNAL TRACKS AI’S INFLUENCE ON EYE CARE
November 01, 2024
NOVEL OCT METRIC PREDICTS VISUAL RECOVERY IN FULL-THICKNESS MACULAR HOLE
November 01, 2024
EARLY ORTHO-K RESPONSE GOOD PREDICTOR OF LONG-TERM OUTCOME, STUDY FINDS
November 01, 2024
LOW BMI LINKED TO POAG PROGRESSION
October 31, 2024
VITREOUS HEMORRHAGE BENEFITS FROM EARLIER VITRECTOMY
October 31, 2024
Previous Load Next Five Next
LOOK INSIDE THE CURRENT ISSUE
NOVEMBER 15, 2024
TABLE OF CONTENTS
ARCHIVE
SUBSCRIPTIONS
FEATURES
Dry Eye
“WHY ISN’T MY DRY EYE THERAPY WORKING?”
When a patient doesn’t respond to treatment, it’s time to revisit the clinical
findings and consider differential diagnoses.
Dry Eye
EXPANDING THE MGD TREATMENT ARSENAL
We explore how new and emerging options get to the root of the problem rather
than merely offering symptomatic relief.
Eyelids
BETWEEN THE SEPTAL DIVIDE: MANAGING PRESEPTAL AND ORBITAL CELLULITIS
Learn how to differentiate and handle these conditions.
Systemic Disease
DISTINGUISHING EPISCLERITIS FROM SCLERITIS IN OPTOMETRIC PRACTICE
Timely and accurate differentiation between these two is essential for proper
management and to prevent severe ocular and systemic complications.
Cornea
SYSTEMIC MEDICATION CONCERNS FOR CORNEAS
This anterior structure can be at risk of various complications from oral drug
use. Let’s look at the most common presentations that ODs should know about.
Clinical Research
THE CLINICAL TRIALS THAT CHANGED EYE CARE
Here’s your guide to over 60 landmark studies that established the protocols of
optometry as it’s practiced today.
DEPARTMENTS
Retina Quiz
TRIPLE TROUBLE
Unpacking this neurovascular clinical triad can be difficult.
You Be the Judge
COMANAGE WITH CAUTION
With refractive surgery complications, which doctor is culpable?
Diagnostic Quiz
CONNECT THE DOTS
A series of white lumps recently developed on a patient’s corneas. What are
they?
Chairside
DISCLOSURES
Your expertise can really contribute beneficially to things like, I don’t know,
saving narwhals.
Clinical Quandaries
NEED A LIFT?
Patients with myasthenia gravis have lots of new options.
Outlook
ON THE SHOULDERS OF GIANTS
We present a guide to eyecare research studies so that you, too, can see further
than those who have come before.
Through My Eyes
TAKE YOUR PICK
There’s almost too many new OSD treatments to choose from.
UPCOMING EVENTS
DECEMBER 6-7, 2024
DECEMBER 7-8, 2024
E-NEWSLETTERS
PRACTICE PEARLS
Expert clinician Paul Karpecki, OD, provides practical insights and management
strategies for a wide array of ocular conditions.
OCCRS E-NEWSLETTER
A quarterly e-newsletter by Optometric Cornea, Cataract and Refractive Society
(OCCRS) covering the latest information on cornea, cataract and refractive
surgery, comanagement and leading technologies.
OPTOMETRIC RETINA SOCIETY E-NEWSLETTER
Keep up to date on the latest research and clinical findings in retinal disease
care with this quarterly publication from the ORS.
OPTOMETRIC PHYSICIAN E-JOURNAL
A weekly e-journal edited by Art Epstein, OD, featuring incisive commentary,
timely research summaries and late-breaking news.
TO SUBSCRIBE TO THESE AND OTHERS, CLICK HERE
CONTINUING EDUCATION
November 2024 • 2.00 Credits
DISTINGUISHING EPISCLERITIS FROM SCLERITIS IN OPTOMETRIC PRACTICE
October 2024 • 2.00 Credits
GUIDELINES FOR IIH MANAGEMENT IN OPTOMETRIC PRACTICE
September 2024 • 2.00 Credits
CAN YOU SPOT THESE DRUG-INDUCED OCULAR SIDE EFFECTS?
August 2024 • 2.00 Credits
A STEPWISE APPROACH TO DIAGNOSING DRY EYE DISEASE
View More CE
ADDITIONAL PUBLICATIONS
* DECIPHERING DRY EYE DISEASE TO IMPROVE PATIENT CARE
Six optometrists discuss the complex role of inflammation and evaporation in
dry eye and teach ODs which steps to take to identify patients early and
promote better outcomes.
Sponsored by Bausch + Lomb
* THE 3 I'S OF GEOGRAPHIC ATROPHY
* WELLNESS ESSENTIALS FOR CLINICAL PRACTICE - 4TH EDITION
* TWO TORICS, ONE UNMATCHED DESIGN
* A BREAKTHROUGH IN NUTRITIONAL SUPPLEMENTATION FOR DRY EYES
* ANNUAL CONTACT LENSES AND LENS CARE GUIDE - 2024
View More Publications
REVIEW OF CORNEA & CONTACT LENSES
NOVEMBER/DECEMBER 2024
TABLE OF CONTENTS
READ DIGITAL EDITION
READ PDF EDITION
* FIGHT AGAINST FUCHS' DYSTROPHY
Recent advances in understanding genetic influences may help manage this
condition.
* CORNEAL COMPLICATIONS OF DIABETES: WHAT ODS NEED TO KNOW
Corneal Complications of Diabetes: What ODs Need to Know
* UNDERSTANDING THE OCULAR MANIFESTATIONS OF HSV
Accurate diagnosis and management require confident knowledge of the unique
ways this disease can present in different layers of the cornea.
* AVOID THESE COMMON SCLERAL LENS MISTAKES
Novices may be unaware of certain intricacies these lenses possess, which can
make a big difference in outcomes.
* CLINICAL APPLICATIONS OF TODAY’S SCLERAL LENS RESEARCH
Catch up on the latest findings and how they can apply to clinical practice.
* SCLERAL LENS DESIGN: BEYOND THE VAULT
Creating proper secondary and peripheral curves helps prevent issues of
comfort and vision quality.
View More
Women In Optometry continues to be published online, with regular updates on
practice design, practice success, news, trends and perspectives. Visit
womeninoptometry.com.
JOB OF THE WEEK
Home Current Issue Subscribe e-Newsletters Continuing Education Meetings
Archives
Patient Handouts Optometric Study Center Editorial Staff Business Staff Media
Kit Multimedia Web Exclusives
Contact Us Privacy Policy Do Not Sell My Personal Information Manage Preferences
Classifieds
Copyright © 2024 Jobson Medical Information LLC unless otherwise noted.
All rights reserved. Reproduction in whole or in part without permission is
prohibited.
×
FULL IMAGE
WE CARE ABOUT YOUR PRIVACY
We and our 57 partners store and access personal data, like browsing data or
unique identifiers, on your device. Selecting "I Accept" enables tracking
technologies to support the purposes shown under "we and our partners process
data to provide," whereas selecting "Reject All" or withdrawing your consent
will disable them. If trackers are disabled, some content and ads you see may
not be as relevant to you. You can resurface this menu to change your choices or
withdraw consent at any time by clicking the Manage Preferences link on the
bottom of the webpage [or the floating icon on the bottom-left of the webpage,
if applicable]. Your choices will have effect within our Website. For more
details, refer to our Privacy Policy.
WE AND OUR PARTNERS PROCESS DATA TO PROVIDE:
Use precise geolocation data. Actively scan device characteristics for
identification. Store and/or access information on a device. Personalised
advertising and content, advertising and content measurement, audience research
and services development. List of Partners (vendors)
I Accept Show Purposes
ABOUT YOUR PRIVACY
We process your data to deliver content or advertisements and measure the
delivery of such content or advertisements to extract insights about our
website. We share this information with our partners on the basis of consent and
legitimate interest. You may exercise your right to consent or object to a
legitimate interest, based on a specific purpose below or at a partner level in
the link under each purpose. These choices will be signaled to our vendors
participating in the Transparency and Consent Framework.
More information
Allow All
MANAGE CONSENT PREFERENCES
Consent Legitimate Interest
STRICTLY NECESSARY COOKIES
Always Active
These cookies are necessary for the website to function and cannot be switched
off in our systems. They are usually only set in response to actions made by you
which amount to a request for services, such as setting your privacy
preferences, logging in or filling in forms. You can set your browser to block
or alert you about these cookies, but some parts of the site will not then work.
These cookies do not store any personally identifiable information.
TARGETING COOKIES
Targeting Cookies
These cookies may be set through our site by our advertising partners. They may
be used by those companies to build a profile of your interests and show you
relevant adverts on other sites. They do not store directly personal
information, but are based on uniquely identifying your browser and internet
device. If you do not allow these cookies, you will experience less targeted
advertising.
PERFORMANCE COOKIES
Performance Cookies
These cookies allow us to count visits and traffic sources so we can measure and
improve the performance of our site. They help us to know which pages are the
most and least popular and see how visitors move around the site. All
information these cookies collect is aggregated and therefore anonymous. If you
do not allow these cookies we will not know when you have visited our site, and
will not be able to monitor its performance.
FUNCTIONAL COOKIES
Functional Cookies
These cookies enable the website to provide enhanced functionality and
personalisation. They may be set by us or by third party providers whose
services we have added to our pages. If you do not allow these cookies then some
or all of these services may not function properly.
STORE AND/OR ACCESS INFORMATION ON A DEVICE 51 PARTNERS CAN USE THIS PURPOSE
Store and/or access information on a device
Cookies, device or similar online identifiers (e.g. login-based identifiers,
randomly assigned identifiers, network based identifiers) together with other
information (e.g. browser type and information, language, screen size, supported
technologies etc.) can be stored or read on your device to recognise it each
time it connects to an app or to a website, for one or several of the purposes
presented here.
List of IAB Vendors | View Illustrations
PERSONALISED ADVERTISING AND CONTENT, ADVERTISING AND CONTENT MEASUREMENT,
AUDIENCE RESEARCH AND SERVICES DEVELOPMENT 57 PARTNERS CAN USE THIS PURPOSE
Personalised advertising and content, advertising and content measurement,
audience research and services development
* USE LIMITED DATA TO SELECT ADVERTISING 46 PARTNERS CAN USE THIS PURPOSE
Switch Label
Switch Label
Advertising presented to you on this service can be based on limited data,
such as the website or app you are using, your non-precise location, your
device type or which content you are (or have been) interacting with (for
example, to limit the number of times an ad is presented to you).
View Illustrations
* CREATE PROFILES FOR PERSONALISED ADVERTISING 38 PARTNERS CAN USE THIS PURPOSE
Switch Label
Information about your activity on this service (such as forms you submit,
content you look at) can be stored and combined with other information about
you (for example, information from your previous activity on this service and
other websites or apps) or similar users. This is then used to build or
improve a profile about you (that might include possible interests and
personal aspects). Your profile can be used (also later) to present
advertising that appears more relevant based on your possible interests by
this and other entities.
View Illustrations
* USE PROFILES TO SELECT PERSONALISED ADVERTISING 38 PARTNERS CAN USE THIS
PURPOSE
Switch Label
Advertising presented to you on this service can be based on your advertising
profiles, which can reflect your activity on this service or other websites
or apps (like the forms you submit, content you look at), possible interests
and personal aspects.
View Illustrations
* CREATE PROFILES TO PERSONALISE CONTENT 13 PARTNERS CAN USE THIS PURPOSE
Switch Label
Information about your activity on this service (for instance, forms you
submit, non-advertising content you look at) can be stored and combined with
other information about you (such as your previous activity on this service
or other websites or apps) or similar users. This is then used to build or
improve a profile about you (which might for example include possible
interests and personal aspects). Your profile can be used (also later) to
present content that appears more relevant based on your possible interests,
such as by adapting the order in which content is shown to you, so that it is
even easier for you to find content that matches your interests.
View Illustrations
* USE PROFILES TO SELECT PERSONALISED CONTENT 11 PARTNERS CAN USE THIS PURPOSE
Switch Label
Content presented to you on this service can be based on your content
personalisation profiles, which can reflect your activity on this or other
services (for instance, the forms you submit, content you look at), possible
interests and personal aspects. This can for example be used to adapt the
order in which content is shown to you, so that it is even easier for you to
find (non-advertising) content that matches your interests.
View Illustrations
* MEASURE ADVERTISING PERFORMANCE 52 PARTNERS CAN USE THIS PURPOSE
Switch Label
Switch Label
Information regarding which advertising is presented to you and how you
interact with it can be used to determine how well an advert has worked for
you or other users and whether the goals of the advertising were reached. For
instance, whether you saw an ad, whether you clicked on it, whether it led
you to buy a product or visit a website, etc. This is very helpful to
understand the relevance of advertising campaigns.
View Illustrations
* MEASURE CONTENT PERFORMANCE 16 PARTNERS CAN USE THIS PURPOSE
Switch Label
Switch Label
Information regarding which content is presented to you and how you interact
with it can be used to determine whether the (non-advertising) content e.g.
reached its intended audience and matched your interests. For instance,
whether you read an article, watch a video, listen to a podcast or look at a
product description, how long you spent on this service and the web pages you
visit etc. This is very helpful to understand the relevance of
(non-advertising) content that is shown to you.
View Illustrations
* UNDERSTAND AUDIENCES THROUGH STATISTICS OR COMBINATIONS OF DATA FROM
DIFFERENT SOURCES 32 PARTNERS CAN USE THIS PURPOSE
Switch Label
Switch Label
Reports can be generated based on the combination of data sets (like user
profiles, statistics, market research, analytics data) regarding your
interactions and those of other users with advertising or (non-advertising)
content to identify common characteristics (for instance, to determine which
target audiences are more receptive to an ad campaign or to certain
contents).
View Illustrations
* DEVELOP AND IMPROVE SERVICES 48 PARTNERS CAN USE THIS PURPOSE
Switch Label
Switch Label
Information about your activity on this service, such as your interaction
with ads or content, can be very helpful to improve products and services and
to build new products and services based on user interactions, the type of
audience, etc. This specific purpose does not include the development or
improvement of user profiles and identifiers.
View Illustrations
* USE LIMITED DATA TO SELECT CONTENT 6 PARTNERS CAN USE THIS PURPOSE
Switch Label
Switch Label
Content presented to you on this service can be based on limited data, such
as the website or app you are using, your non-precise location, your device
type, or which content you are (or have been) interacting with (for example,
to limit the number of times a video or an article is presented to you).
View Illustrations
List of IAB Vendors
USE PRECISE GEOLOCATION DATA 14 PARTNERS CAN USE THIS SPECIAL FEATURE
Use precise geolocation data
With your acceptance, your precise location (within a radius of less than 500
metres) may be used in support of the purposes explained in this notice.
List of IAB Vendors
ACTIVELY SCAN DEVICE CHARACTERISTICS FOR IDENTIFICATION 3 PARTNERS CAN USE THIS
SPECIAL FEATURE
Actively scan device characteristics for identification
With your acceptance, certain characteristics specific to your device might be
requested and used to distinguish it from other devices (such as the installed
fonts or plugins, the resolution of your screen) in support of the purposes
explained in this notice.
List of IAB Vendors
ENSURE SECURITY, PREVENT AND DETECT FRAUD, AND FIX ERRORS 49 PARTNERS CAN USE
THIS SPECIAL PURPOSE
Always Active
Your data can be used to monitor for and prevent unusual and possibly fraudulent
activity (for example, regarding advertising, ad clicks by bots), and ensure
systems and processes work properly and securely. It can also be used to correct
any problems you, the publisher or the advertiser may encounter in the delivery
of content and ads and in your interaction with them.
List of IAB Vendors | View Illustrations
DELIVER AND PRESENT ADVERTISING AND CONTENT 43 PARTNERS CAN USE THIS SPECIAL
PURPOSE
Always Active
Certain information (like an IP address or device capabilities) is used to
ensure the technical compatibility of the content or advertising, and to
facilitate the transmission of the content or ad to your device.
List of IAB Vendors | View Illustrations
MATCH AND COMBINE DATA FROM OTHER DATA SOURCES 39 PARTNERS CAN USE THIS FEATURE
Always Active
Information about your activity on this service may be matched and combined with
other information relating to you and originating from various sources (for
instance your activity on a separate online service, your use of a loyalty card
in-store, or your answers to a survey), in support of the purposes explained in
this notice.
List of IAB Vendors
LINK DIFFERENT DEVICES 35 PARTNERS CAN USE THIS FEATURE
Always Active
In support of the purposes explained in this notice, your device might be
considered as likely linked to other devices that belong to you or your
household (for instance because you are logged in to the same service on both
your phone and your computer, or because you may use the same Internet
connection on both devices).
List of IAB Vendors
IDENTIFY DEVICES BASED ON INFORMATION TRANSMITTED AUTOMATICALLY 36 PARTNERS CAN
USE THIS FEATURE
Always Active
Your device might be distinguished from other devices based on information it
automatically sends when accessing the Internet (for instance, the IP address of
your Internet connection or the type of browser you are using) in support of the
purposes exposed in this notice.
List of IAB Vendors
SAVE AND COMMUNICATE PRIVACY CHOICES 38 PARTNERS CAN USE THIS SPECIAL PURPOSE
Always Active
The choices you make regarding the purposes and entities listed in this notice
are saved and made available to those entities in the form of digital signals
(such as a string of characters). This is necessary in order to enable both this
service and those entities to respect such choices.
List of IAB Vendors | View Illustrations
Back Button
COOKIE LIST
Search Icon
Filter Icon
Clear
checkbox label label
Apply Cancel
Consent Leg.Interest
checkbox label label
checkbox label label
checkbox label label
Accept Essential Confirm My Choices